SS
CGEM icon

SBI Securities’s Cullinan Oncology CGEM Stock Holding History

SBI Securities’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18 Hold
1
– – ﹤0.01% 3864
2026
Q1 		$14 Hold
1
– – ﹤0.01% 3807
2025
Q4 		$10 Sell
1
-1
-50% -$9 ﹤0.01% 3874
2025
Q3 		$12 Buy
2
+1
+100% +$7 ﹤0.01% 4004
2025
Q2 		$8 Hold
1
– – ﹤0.01% 4035
2025
Q1 		$8 Hold
1
– – ﹤0.01% 3986
2024
Q4 		$12 Buy
+1
New +$14 ﹤0.01% 3902

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

SBI Securities's CGEM Position: Q2 2026 in Review

SBI Securities held its Cullinan Oncology (CGEM) position steady in Q2 2026 at 1 share worth $18. The position accounts for ﹤0.01% of the portfolio, ranked #3864.

SBI Securities first reported a position in CGEM in Q4 2024 and has held it in 7 quarters since. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • SBI Securities held 1 share of Cullinan Oncology worth $18 as of Q2 2026.
  • SBI Securities left its Cullinan Oncology share count unchanged in Q2 2026.
  • Cullinan Oncology made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3864 holding.
  • SBI Securities first reported a position in Cullinan Oncology in Q4 2024 and has held it in 7 quarters since.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.